Search research articles
Contact Us
Filters
Showing results (201-210 of 299) with videos related to
Page
of 30
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2019
Erratum to 'Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)' [Eur J Cancer 107 (January 2019) 46-52]
S Watson, C de la Fouchardière, S Kim, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Cancer Treatment Reviews
|
December 26, 2021
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
Jean-François Delattre, Ayse Selcen Oguz Erdogan, Romain Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2019
Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Nicolas Meillan, Dewi Vernerey, Jérémie H Lefèvre, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
Nature Communications
|
August 2, 2017
Charge carrier localised in zero-dimensional (CH<sub>3</sub>NH<sub>3</sub>)<sub>3</sub>Bi<sub>2</sub>I<sub>9</sub> clusters
Chengsheng Ni, Gordon Hedley, Julia Payne, et al.
Neuroendocrinology
|
September 4, 2015
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
Jerome Cros, Emilie Moati, Jerome Raffenne, et al.
Journal of the National Cancer Institute
|
October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
Alexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Anais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 299) with videos related to
Sort By:
Page
of 30
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2019
Erratum to 'Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)' [Eur J Cancer 107 (January 2019) 46-52]
S Watson, C de la Fouchardière, S Kim, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer
Kaysia Ludford, Romain Cohen, Magali Svrcek, et al.
Cancer Treatment Reviews
|
December 26, 2021
A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification
Jean-François Delattre, Ayse Selcen Oguz Erdogan, Romain Cohen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 13, 2019
Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Nicolas Meillan, Dewi Vernerey, Jérémie H Lefèvre, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
Nature Communications
|
August 2, 2017
Charge carrier localised in zero-dimensional (CH<sub>3</sub>NH<sub>3</sub>)<sub>3</sub>Bi<sub>2</sub>I<sub>9</sub> clusters
Chengsheng Ni, Gordon Hedley, Julia Payne, et al.
Neuroendocrinology
|
September 4, 2015
Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors
Jerome Cros, Emilie Moati, Jerome Raffenne, et al.
Journal of the National Cancer Institute
|
October 7, 2010
Azathioprine-induced carcinogenesis in mice according to Msh2 genotype
Alexandra Chalastanis, Virginie Penard-Lacronique, Magali Svrcek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2014
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Anais Laforest, Thomas Aparicio, Aziz Zaanan, et al.
The Oncologist
|
April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
Raphael Colle, Sara Lonardi, Marine Cachanado, et al.
Page
of 30